BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37945379)

  • 1. Prognostic Value of
    Carlier T; Frécon G; Mateus D; Rizkallah M; Kraeber-Bodéré F; Kanoun S; Blanc-Durand P; Itti E; Le Gouill S; Casasnovas RO; Bodet-Milin C; Bailly C
    J Nucl Med; 2024 Jan; 65(1):156-162. PubMed ID: 37945379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics signature from [
    Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
    Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Eertink JJ; van de Brug T; Wiegers SE; Zwezerijnen GJC; Pfaehler EAG; Lugtenburg PJ; van der Holt B; de Vet HCW; Hoekstra OS; Boellaard R; Zijlstra JM
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):932-942. PubMed ID: 34405277
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Cui Y; Jiang Y; Deng X; Long W; Liu B; Fan W; Li Y; Zhang X
    Acad Radiol; 2023 Jul; 30(7):1408-1418. PubMed ID: 36437191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stacking Ensemble Learning-Based [
    Zhao S; Wang J; Jin C; Zhang X; Xue C; Zhou R; Zhong Y; Liu Y; He X; Zhou Y; Xu C; Zhang L; Qian W; Zhang H; Zhang X; Tian M
    J Nucl Med; 2023 Oct; 64(10):1603-1609. PubMed ID: 37500261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
    Ceriani L; Milan L; Cascione L; Gritti G; Dalmasso F; Esposito F; Pirosa MC; Schär S; Bruno A; Dirnhofer S; Giovanella L; Hayoz S; Mamot C; Rambaldi A; Chauvie S; Zucca E
    Hematol Oncol; 2022 Feb; 40(1):11-21. PubMed ID: 34714558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a [
    Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
    Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of Dmax and %ΔSUVmax of
    Dang J; Peng X; Wu P; Yao Y; Tan X; Ye Z; Jiang X; Jiang X; Liu Y; Chen S; Cheng Z
    BMC Med Imaging; 2023 Oct; 23(1):173. PubMed ID: 37907837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline
    Jing F; Liu Y; Zhao X; Wang N; Dai M; Chen X; Zhang Z; Zhang J; Wang J; Wang Y
    EJNMMI Res; 2023 Oct; 13(1):92. PubMed ID: 37884763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with
    Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T
    Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
    Eertink JJ; Zwezerijnen GJC; Cysouw MCF; Wiegers SE; Pfaehler EAG; Lugtenburg PJ; van der Holt B; Hoekstra OS; de Vet HCW; Zijlstra JM; Boellaard R
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4642-4651. PubMed ID: 35925442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [
    de Jesus FM; Yin Y; Mantzorou-Kyriaki E; Kahle XU; de Haas RJ; Yakar D; Glaudemans AWJM; Noordzij W; Kwee TC; Nijland M
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1535-1543. PubMed ID: 34850248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline
    Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
    Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic and Prognostic Value of
    Chen X; Qiao WL; Song JH; Liu CC; Han L; Wu S; Zhao JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1044-1049. PubMed ID: 37551475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.
    Zhou Y; Zhang B; Han J; Dai N; Jia T; Huang H; Deng S; Sang S
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11549-11560. PubMed ID: 37395846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinction of Lymphoma from Sarcoidosis on
    Lovinfosse P; Ferreira M; Withofs N; Jadoul A; Derwael C; Frix AN; Guiot J; Bernard C; Diep AN; Donneau AF; Lejeune M; Bonnet C; Vos W; Meyer PE; Hustinx R
    J Nucl Med; 2022 Dec; 63(12):1933-1940. PubMed ID: 35589406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
    Eertink JJ; Pfaehler EAG; Wiegers SE; van T; Brug D; Lugtenburg PJ; Hoekstra OS; Zijlstra JM; de Vet HCW; Boellaard R
    J Nucl Med; 2022 Mar; 63(3):389-395. PubMed ID: 34272315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of baseline 2-[
    Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
    Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.